Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Vijaya Mukthinuthalapati

Gastroenterology Santa Cruz, CA Medical Doctor

NPI 1164874855 CMS profile 2453558

1663 Dominican Way Ste 210, Santa Cruz, CA 95065

Open in the dashboard

General payments

$2,409

25 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Vijaya Mukthinuthalapati of Santa Cruz, CA is reported in the CMS Open Payments database as having received $2,409 across 25 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 51st percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,660 18
2022 General $749 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vijaya Mukthinuthalapati
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Vijaya Mukthinuthalapati were reported at $1,660. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Vijaya Mukthinuthalapati Gastroenterology median Middle half National median
2019 $0 $417 $126–$1,100 $163
2020 $0 $224 $74–$624 $114
2021 $0 $352 $106–$1,054 $132
2022 $749 $448 $129–$1,270 $149
2023 $0 $533 $150–$1,390 $160
2024 $0 $605 $160–$1,606 $164
2025 $1,660 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Olympus Corporation of the Americas $2,323 22 payments
  2. Boston Scientific Corporation $43 1 payment
  3. Incyte Corporation $25 1 payment
  4. Olympus America Inc. $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $2,185 14 payments
  2. Food and Beverage $224 11 payments
Products named General payments · program years 2022–2025
  1. Single Use Electrosurgical Knife KD-655 $2,323 22 payments
  2. Olympus $2,279 20 payments
  3. DISPOSABLE DISTAL ATTACHMENT EndoTherapy $1,574 15 payments
  4. DISPOSABLE DISTAL ATTACHMENT EndoTherapy $705 5 payments
  5. VISIGLIDE EndoTherapy $705 5 payments
  6. Single Use Electrosurgical Hemostatic Forceps $44 2 payments
  7. OverStitch Endoscopic Suturing System $43 1 payment
  8. MONJUVI $25 1 payment
  9. VISIGLIDE EndoTherapy $19 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

322

Median for Gastroenterology: 569

Drug cost

$15,983

Median for Gastroenterology: $104,976

Branded share of claims

74.5%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates Brand 226 $14,643
Omeprazole Generic 45 $595
Pantoprazole Sodium Generic 24 $359
Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 14 $209
Dicyclomine Hcl Generic 13 $177

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$104,848

Medicare's payments for the services billed

Medicare patients

387

Average age 74

Services billed

903

200 women, 187 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 44%
Depression 26%
Diabetes 23%
Ischemic heart disease 23%
Chronic kidney disease 23%
Atrial fibrillation 22%
Cancer 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

25 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record